» Authors » Minghuan Jiang

Minghuan Jiang

Explore the profile of Minghuan Jiang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 679
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Jiang M, Gong Y, Fang Y, Yao X, Feng L, Zhu S, et al.
Int J Environ Res Public Health . 2022 Feb; 19(4). PMID: 35206343
The influenza vaccination coverage among children is low in China. We aimed to conduct a nationwide survey to quantify parental preferences and willingness to pay (WTP) for influenza vaccination for...
12.
Zhou H, Nie X, Jiang M, Dong W
J Clin Pharm Ther . 2021 Nov; 47(4):523-530. PMID: 34783090
What Is Known And Objective: With the high cost, the long-term persistence of new oral anticoagulants (NOACs) was lower than that of warfarin in Chinese patients with non-valvular atrial fibrillation...
13.
Xiang Y, Ren B, Chen Y, Jiang M, Wang N, Niu R, et al.
Biol Pharm Bull . 2021 May; 44(5):620-626. PMID: 33952818
The prevalence of type 2 diabetes mellitus (T2DM) is increasing rapidly in China. Glycemic control is vital in this patient population. We designed a cross-sectional questionnaire to investigate glycemic control...
14.
Jiang M, Li P, Yao X, Hayat K, Gong Y, Zhu S, et al.
Hum Vaccin Immunother . 2021 May; 17(9):3119-3125. PMID: 33950797
The influenza vaccination uptake rate is low in China. In the current study, we aimed to explore the preferences of influenza vaccination among the Chinese elderly. A discrete choice experiment...
15.
Saeed A, Saeed F, Saeed H, Saleem Z, Yang C, Chang J, et al.
Front Pharmacol . 2021 Mar; 11:595008. PMID: 33708114
This national survey was aimed at measuring the access to cardiovascular disease (CVD) medicines in terms of their availability, price, and affordability in Pakistan. This was done by using the...
16.
Li P, Hayat K, Jiang M, Pu Z, Yao X, Zou Y, et al.
BMC Public Health . 2021 Jan; 21(1):222. PMID: 33499830
Background: Influenza is a global health threat to older adults, and the influenza vaccine is the most effective approach to prevent influenza infection. However, influenza vaccination coverage among Chinese older...
17.
Kabba J, Koroma M, James P, Kitchen C, Xu S, Chang J, et al.
Br J Clin Pharmacol . 2021 Jan; 89(1):20-33. PMID: 33398910
Aims: Irrational medicine use is a global crisis, but incidences are proportionately higher in low- and middle-income countries such as Sierra Leone. This study explores the structure, functions and challenges...
18.
Yang C, Hu S, Ye D, Jiang M, Babar Z, Fang Y
Front Pharmacol . 2020 Dec; 11:602421. PMID: 33381042
To evaluate the price and availability of medicines in China. A standard methodology developed by WHO and Health Action International was used to collect medicine price and availability data. We...
19.
Liu W, Gillani A, Xu S, Chen C, Chang J, Yang C, et al.
Int J Environ Res Public Health . 2020 Dec; 18(1). PMID: 33375251
In this study, we investigated the trends and patterns of antibiotic consumption (macrolides and lincosamides) in China's healthcare institutions from 2015 to 2017. The China Drug Supply Information Platform (CDSIP)...
20.
Yan K, Yang C, Zhang H, Ye D, Liu S, Chang J, et al.
BMJ Open . 2020 Nov; 10(11):e037034. PMID: 33243788
Objective: The aim of this study was to measure the impact of zero-mark-up drug policy (ZMDP) on drug-related expenditures and use in urban hospitals. Design: This was a retrospective observational...